| Dr John Louis Etcheverry, DPM | |
|
2400 Bahamas Dr, Suite 200, Bakersfield, CA 93309-0745 | |
| (661) 328-2323 | |
| (661) 328-5573 |
| Full Name | Dr John Louis Etcheverry |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 28 Years |
| Location | 2400 Bahamas Dr, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760573745 | NPI | - | NPPES |
| P00904698 | Other | CA | RAILROAD MEDICARE |
| 000E40990 | Other | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | E4099 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 0547490534 | 108 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2010.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
› Verified 2 days ago
| Provider Name | Regents Of The University Of California |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750723540 PECOS PAC ID: 0547490534 Enrollment ID: O20140314000181 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2010.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Louis Etcheverry, DPM 2400 Bahamas Dr, Suite 200, Bakersfield, CA 93309-0745 Ph: (661) 328-2323 | Dr John Louis Etcheverry, DPM 2400 Bahamas Dr, Suite 200, Bakersfield, CA 93309-0745 Ph: (661) 328-2323 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2010.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
› Verified 2 days ago
Stockdale Podiatry Group Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1666 Fax: 661-832-2039 | |
Thomas D Nelson Dpm Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1701 27th St, Bakersfield, CA 93301 Phone: 661-322-2895 Fax: 661-322-2897 | |
Dr. James Francis Brown, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Dr. Brandon James Hawkins, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Dr. Allan Evangelista, D.P.M., M.P.H. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Ali Ghorbanifarajzadeh, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 500 Old River Rd Ste 185, Bakersfield, CA 93311 Phone: 661-832-3600 Fax: 661-322-6249 | |
Carlos J. Rodriguez, DPM, MS, PA Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 |